High Ly6H mRNA expression in lung cancer was significantly correlated with poor five-year first progression free survival (low Ly6H, n=557; high Ly6E, n=425; HR=1.77, p=2.90E-09), five-year post progression free survival (low Ly6H, n=87; high Ly6E, n=257; HR=1.47, p=0.015) and five-year overall survival (low Ly6H, n=484; high Ly6E, n=1442; HR=1.3, p=6.00E-04) shown by KM plotter (Table S3, Figure 3B). This evidence concerns the gene LY6H and lung carcinoma.